SEC Form 4 · accession 0000905718-18-000817
Matinas BioPharma Holdings, Inc. · MTNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Herbert J Conrad
Director
Period of report
Oct 1, 2018
Accepted (ET)
Oct 3, 2018 · 4:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001582554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 1, 2018 | A | 26,087 | $0.00 | A | 3,992,566 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On October 1, 2018, the Reporting Person was granted 26,087 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equit Compensation Plan. Such shares vest immediately upon grant.